New EEG Device Enables Cross-Regional Synchronous Collection from Thousands, Boosts Brain-Engineering Stocks

Brain-engineering concept stocks traded actively during the session on the 27th. As of press time, Aipeng Medical hit the 20% daily limit, Beiyikang rose over 17%, Chengdu Huawei rose over 15%, Sanbo Brain and Beiqingsong each rose over 10%, and Innovation Medical and Saili Medical also hit their daily limits.

On the news front, a Chinese research team recently released a new EEG signal acquisition device, achieving for the first time globally the synchronous collection of EEG signals from over a thousand people across different regions. This marks a key step forward in the training of neural large models and the development of general brain-computer interface technology.

The brain-computer interface industry is primarily oriented toward the medical and health sector, with sustained demand for applications such as motor function restoration, neural rehabilitation, and assisted treatment of brain diseases. The industry is characterized by high technology intensity and cross-disciplinary integration, covering multiple segments including basic materials, core components, system integration, and application services, and involves fields such as neuroscience, microelectronics, biomaterials, artificial intelligence, medical devices, and high-end equipment manufacturing. The industry chain can be divided into three main segments: upstream core components, midstream systems and platforms, and downstream application scenarios. Upstream core technology is key to industrial competitiveness, midstream system integration capability determines product competitiveness, and downstream medical and health applications are the main driving force for current industrial development.